Improving Knowledge and Awareness of Preventive Antibodies for RSV Infants and Young Children

Tools to Facilitate RSV Prevention

* Resources for Clinicians * Practical Considerations

Clinical Recommendations for RSV Prevention

* Organizational Guidance * Infants <8 Months * Infants/Young Children 8-19 Months * Antibody Administration

RSV Immunoprophylaxis Strategies in Infants/Young Children

* Historical Use of Palivizumab * Basics of RSV Antibodies * Nirsevimab * Clesrovimab

RSV Immunoprophylaxis Strategies in Pregnant Parents

* Pregnant Parent Vaccination (RSVpreF)

RSV Infection in Infants/Children

* Epidemiology * Morbidity and Mortality * Signs and Symptoms * Risk Factors * Acute and Chronic Complications